Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sohm Inc SHMN

SOHM, Inc. is a pharmaceutical manufacturer that produces and markets generic drugs for various treatment categories. The Company is focused on developing, manufacturing and distributing generic, branded generic, private label pharmaceuticals, cosmeceuticals and nutraceutical products. The Company has expertise in various drug delivery technologies, including solid dosage from, oral-controlled... see more

Recent & Breaking News (OTCPK:SHMN)

NOTICE TO DISREGARD - SOHM, Inc.

GlobeNewswire August 9, 2018

SOHM, Inc. Subsidiary Daiichi Sankyo Group Files Its Acute Myeloid Leukemia (AML) Treatment Quizartinib in the US; the FDA Awarded Breakthrough Status for The Drug

GlobeNewswire August 9, 2018

SOHM, Inc. Announces Potential Purchase Orders for a Range of Pharmaceutical Products

GlobeNewswire August 2, 2018

SOHM, Inc. Fully Paid Nevada Secretary of State Fee and is Seeking to be OTC Current 

GlobeNewswire August 1, 2018

SOHM, Inc. Files All Quarterly and Annual Financials to Move Current with OTC

GlobeNewswire July 26, 2018

SOHM, Inc. Announces No Reverse Split and No Increase of Authorize Shares

GlobeNewswire July 24, 2018

SOHM, Inc. Reports $180,000 of Total Revenue and a Gross Profit of $95,292 for the First Qtr of 2018

GlobeNewswire July 17, 2018

SOHM, Inc., Executes Non-Toxic Funding Commitment with Institutional Investor for Expansion of Core Business to Adopt Blockchain Technologies

GlobeNewswire January 19, 2018

SOHM, Inc., TO ENTER ICO BITCOIN MARKET

GlobeNewswire December 5, 2017

SOHM, Inc., Announces Relaunch of Flagship Skincare Product in USA

GlobeNewswire December 5, 2017

SOHM Launches Unique Protein Supplement with Multivitamins in US

GlobeNewswire November 29, 2017

SOHM, Inc., Cancellation of Reverse Stock Split

GlobeNewswire November 29, 2017

SUSS MicroTec Launches LI Series - the New Operator-Assisted Surface Laser Imagers

Business Wire May 18, 2016

SOHM Signs Private Label Contract Manufacturing Agreement for Nutraceutical Products

Marketwired April 2, 2015

SOHM Received Confirmed Orders for OTC Products

Marketwired January 5, 2015

SOHM Announces Appointing of Chair of Advisory Board Team

Marketwired December 4, 2014

SOHM, Inc. Announce Share Holder Update an Outlook for 2015

Marketwired October 27, 2014

SOHM, Inc. Receives Confirmation for Test Marketing of Its OTC Products From a Retail Chain Store

Marketwired April 22, 2014

SOHM, Inc. Receives Confirmation for Test Marketing of Its OTC Products From a Retail Chain Store

Marketwired April 22, 2014

SOHM Announces Financial Results for 2013

Marketwired April 9, 2014